| scholarly article | Q13442814 |
| P50 | author | Nuria Farré | Q59662532 |
| José-Maria Verdú-Rotellar | Q85645416 | ||
| P2093 | author name string | Cristina Enjuanes | |
| Josep Comín-Colet | |||
| Miguel Cainzos-Achirica | |||
| Montse Bustins | |||
| Emili Vela | |||
| Montse Clèries | |||
| Pedro Moliner | |||
| Sonia Ruiz | |||
| P2860 | cites work | The meaning and use of the area under a receiver operating characteristic (ROC) curve | Q29547182 |
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. | Q30358659 | ||
| Heart failure and preserved left ventricular function: long term clinical outcome | Q31075676 | ||
| Comorbidity measures for use with administrative data | Q32144770 | ||
| Hospitalizations after heart failure diagnosis a community perspective | Q33577303 | ||
| Impact of prior admissions on 30-day readmissions in medicare heart failure inpatients | Q33597210 | ||
| Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction | Q33916711 | ||
| Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis | Q34050674 | ||
| Heart failure re-admission: measuring the ever shortening gap between repeat heart failure hospitalizations | Q34165908 | ||
| Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies | Q34308075 | ||
| Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases | Q34439990 | ||
| Outcomes in patients with heart failure treated in hospitals with varying admission rates: population-based cohort study | Q34631284 | ||
| Hospital readmissions of patients with heart failure: the impact of hospital and primary care organizational factors in Northern Italy. | Q35641130 | ||
| Heart rate at hospital discharge in patients with heart failure is associated with mortality and rehospitalization | Q36085763 | ||
| Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. | Q36393927 | ||
| Heart failure–associated hospitalizations in the United States | Q37337981 | ||
| Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association | Q37538031 | ||
| Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fraction | Q38422077 | ||
| Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations | Q38463132 | ||
| Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models | Q38571973 | ||
| Meta-Analysis of Risks for Short-Term Readmission in Patients With Heart Failure. | Q38698072 | ||
| Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society | Q38805091 | ||
| Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. | Q38998947 | ||
| Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people | Q39069454 | ||
| The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database | Q40120403 | ||
| Recent Trends in Heart Failure-related Mortality: United States, 2000-2014. | Q40148716 | ||
| Efficacy of an integrated hospital-primary care program for heart failure: a population-based analysis of 56,742 patients. | Q40187361 | ||
| Comparison of Risk of Re-hospitalization, All-Cause Mortality, and Medical Care Resource Utilization in Patients With Heart Failure and Preserved Versus Reduced Ejection Fraction. | Q40667587 | ||
| Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients. | Q40784558 | ||
| The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). | Q40931461 | ||
| Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial | Q40954420 | ||
| Access to heart failure care post emergency department visit: do we meet established benchmarks and does it matter? | Q41969840 | ||
| Out-of-pocket medical spending for care of chronic conditions | Q42668693 | ||
| Effect of multiple chronic conditions among working-age adults. | Q43867611 | ||
| In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry | Q44199904 | ||
| Predictors of cause-specific hospital readmission in patients with heart failure | Q44217420 | ||
| Risk stratification after hospitalization for decompensated heart failure | Q45187905 | ||
| Predicting the risk of unplanned readmission or death within 30 days of discharge after a heart failure hospitalization. | Q45411384 | ||
| EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). | Q46275793 | ||
| Prevalence of heart failure in the Spanish general population aged over 45 years. The PRICE Study. | Q46303668 | ||
| Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme | Q46644013 | ||
| Systolic and diastolic heart failure in the community | Q48376632 | ||
| The validity of heart failure diagnoses obtained from administrative registers | Q48653830 | ||
| Adherence to the ESC Heart Failure Treatment Guidelines in Spain: ESC Heart Failure Long-term Registry. | Q53226673 | ||
| Risk-stratification methods for identifying patients for care coordination. | Q54491846 | ||
| Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure | Q57396308 | ||
| Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population | Q57630247 | ||
| The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure | Q59187009 | ||
| The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure | Q62023655 | ||
| Repeated hospitalizations predict mortality in the community population with heart failure | Q80648854 | ||
| [Heart failure in outpatients: comorbidities and management by different specialists. The EPISERVE Study] | Q81500683 | ||
| Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP Study | Q81617214 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| P304 | page(s) | e0172745 | |
| P577 | publication date | 2017-02-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients | |
| P478 | volume | 12 |
| Q91709829 | A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project |
| Q89731349 | Association Between Cystatin C and Cardiac Function and Long-Term Prognosis in Patients with Chronic Heart Failure |
| Q47186244 | Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain). |
| Q98161478 | Diabetes mellitus and risk of new-onset and recurrent heart failure: a systematic review and meta-analysis |
| Q94453269 | ETS2 and microRNA-155 regulate the pathogenesis of heart failure through targeting and regulating GPR18 expression |
| Q92612078 | Heart Failure Awareness Day: A Tribute to the Genius Carlos Chagas |
| Q103032639 | Impact of sex differences in co-morbidities and medication adherence on outcome in 25 776 heart failure patients |
| Q92509907 | Management of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines: The Linx Registry |
| Q104584455 | PRADOC: a trial on the efficiency of a transition care management plan for hospitalized patients with heart failure in France |
| Q57147205 | Paradox of self-care gender differences among Italian patients with chronic heart failure: findings from a real-world cross-sectional study |
| Q59136983 | Passive Stiffness of Left Ventricular Myocardial Tissue Is Reduced by Ovariectomy in a Post-menopause Mouse Model |
| Q91840364 | Performance of Comprehensive Risk Adjustment for the Prediction of In-Hospital Events Using Administrative Healthcare Data: The Queralt Indices |
| Q39430464 | Physical activity in patients with COPD: the impact of comorbidities. |
| Q55400361 | Population-based analysis of patients with COPD in Catalonia: a cohort study with implications for clinical management. |
| Q92704926 | Prognostication of Poor Survival After Cardiac Resynchronization Therapy |
| Q55386438 | Risk and temporal order of disease diagnosis of comorbidities in patients with COPD: a population health perspective. |
| Q98466834 | Statistics of heart failure and mechanical circulatory support in 2020 |
| Q90118341 | Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis |
| Q98170060 | The conventional isoproterenol-induced heart failure model does not consistently mimic the diaphragmatic dysfunction observed in patients |
| Q64076298 | Validity of the Seattle Heart Failure Model after heart failure hospitalization |
Search more.